A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women
PHASE1CompletedINTERVENTIONAL
Enrollment
21
Participants
Timeline
Start Date
January 31, 2015
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Conditions
Female Sexual Health
Interventions
DRUG
Sildenafil
Trial Locations (1)
33014-3616
Clinical Pharmacology of Miami, Inc., Miami
All Listed Sponsors
lead
Strategic Science & Technologies, LLC
INDUSTRY
NCT02364882 - A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women | Biotech Hunter | Biotech Hunter